A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.
about
In vitro and in vivo anti-angiogenic activities of Panduratin AScreening therapeutic EMT blocking agents in a three-dimensional microenvironmentProteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types.Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturationThe combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-1α expressionBlockade of vascular angiogenesis by Aspergillus usamii var. shirousamii-transformed Angelicae Gigantis Radix and Zizyphus jujuba.Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.Autodigestion: Proteolytic Degradation and Multiple Organ Failure in ShockQuantification of cancer cell extravasation in vivo.When the endothelium scores an own goal: endothelial cells actively augment metastatic extravasation through endothelial-mesenchymal transition.Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.Panduratin A, a possible inhibitor in metastasized A549 cells through inhibition of NF-kappa B translocation and chemoinvasion.Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation.Morphine and breast tumor metastasis: the role of matrix-degrading enzymes.Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes
P2860
Q27301905-A582A918-9DEA-4764-A673-4A4E2D10EFB9Q33689694-AB6F575A-1461-4B6A-9FF2-619236937231Q35032566-327BE1F1-3681-403C-82E3-91DADD85AB4FQ35208820-939D4359-19AF-491A-BBB3-5BBED88E5FCEQ36684583-43C1421E-9705-40CC-95B2-E894778C1F7CQ37457386-2C4378D2-B220-40AB-B56F-5D93C9285BB3Q37535022-EC22A7F6-B07F-4509-8D50-C62B048E9C78Q38683032-25C1E22C-B5D4-4E96-AD40-F40F2126B829Q38776380-8233C7EC-E3E9-4A78-A548-42042A32EE43Q38780879-3EFC8610-9B5F-422C-84A2-A2C41C8A76E4Q38931798-7766C89F-1CA8-4B14-A969-7971F0616405Q39120218-97E20DB7-CDE1-4893-B07E-F69E0B5823CBQ39689348-E4DDD36E-FECC-47C9-8426-A068F6664E39Q41611463-6854C3FB-7E08-477C-8A1E-3D288B8CE7DCQ45093712-36BBF6E2-D974-4EBB-B801-8F3ADDCBAC5FQ58716411-4ABE271B-317A-4203-AAFB-3D8FD6D9C3BD
P2860
A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A role for endothelial-derived ...... ial-basement membrane barrier.
@en
A role for endothelial-derived ...... ial-basement membrane barrier.
@nl
type
label
A role for endothelial-derived ...... ial-basement membrane barrier.
@en
A role for endothelial-derived ...... ial-basement membrane barrier.
@nl
prefLabel
A role for endothelial-derived ...... ial-basement membrane barrier.
@en
A role for endothelial-derived ...... ial-basement membrane barrier.
@nl
P2093
P1476
A role for endothelial-derived ...... ial-basement membrane barrier.
@en
P2093
Alison Breen
Hamed Kargozaran
Jerome W Breslin
Katherine D Watson
Nathalie Gaudreault
Sarah Y Yuan
P2860
P2888
P304
P356
10.1007/S10585-007-9086-6
P577
2007-07-25T00:00:00Z